Clinical trials: Pediatric Immune Mediated Interstitial Lung Disease
Pediatric Immune Mediated Interstitial Lung Disease
Diagnostic and Prognostic Utility of IL-6 and MMP-7 in Pediatric Immune Mediated Interstitial Lung Disease
Pediatric interstitial lung disease (ILD) represents a heterogeneous group of rare but potentially severe pulmonary disorders characterized by diffuse parenchymal involvement and impaired gas exchange.
- Trial name
- NCT07559435
- Testing
- IL-6 (interlukin 6), High-Resolution Computed Tomography (HRCT):, Pulmonary Function Tests (PFTs)
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Sohag University